𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia

✍ Scribed by Livia Pisciotta; Claudio Priore Oliva; Angelo Baldassare Cefalù; Davide Noto; Antonella Bellocchio; Raffaele Fresa; Alfredo Cantafora; Dilip Patel; Maurizio Averna; Patrizia Tarugi; Sebastiano Calandra; Stefano Bertolini

Book ID
118420957
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
232 KB
Volume
186
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The molecular basis of familial hypercho
The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene
✍ Marianne Abifadel; Jean-Pierre Rabès; Sélim Jambart; Georges Halaby; Marie-Hélèn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

Autosomal dominant hypercholesterolemia (ADH), a major risk for coronary heart disease, is associated with mutations in the genes encoding the low-density lipoproteins receptor (LDLR), its ligand apolipoprotein B (APOB) or PCSK9 (Proprotein Convertase Subtilin Kexin 9). Familial hypercholesterolemia

Novel mutations of the PCSK9 gene cause
Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia
✍ Delphine Allard; Sabine Amsellem; Marianne Abifadel; Mélanie Trillard; Martine D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Autosomal dominant hypercholesterolemia (ADH) is a frequent (1/500) monogenic inherited disorder characterized by isolated elevation of LDL leading to premature cardiovascular disease. ADH is known to result from mutations at two main loci: LDLR (encoding the low density lipoprotein receptor), and A